Search

everythinglearnresearchcommunity

for

Search:↓

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

The Ysc84/SH3yl1 protein family is important for cell movement and the process of taking in materials by interacting with actin and cell membranes.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Further research is needed to improve hair regeneration using stem cells and nanomaterials.

Apoptosis is crucial for healthy skin and treating skin diseases.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Key proteins and potential drugs for treating alopecia areata were identified.

Skin organoids can mimic human skin responses to injury and inflammation, making them useful for studying skin diseases and testing treatments.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The study found that a specific area of the hair follicle helps start hair growth by reducing the blocking effects on certain cells and controlling growth signals.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Pertussis toxin may contribute to hair loss in alopecia areata.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Certain cells outside the hair follicle's bulge area can quickly regenerate damaged hair follicles, potentially helping to reduce hair loss from cancer treatments.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

New nanofiber technology improves wound healing by supporting cell growth and delivering treatments directly to the wound.